Dental pulp stem cells (DPSCs) from adult teeth express neural crest (NC) markers together with core transcriptional factors associated with stem cell pluripotency, such as Oct4a, Sox2, Rex1, Stella/ Dppa3, Ssea1/Fut4, Lin28 and Nanog. The possibility to boost the natural stemness features of DPSCs by mild methods, that do not involve gene and/or chromatin modification or gene transfection, is highly desirable for cell therapy. Canonical Wnt and Notch are two highly conserved developmental signalling pathways that are involved in NC emergence and stem cell self-renewal. We determined that both pathways coordinate to regulate the expression of core pluripotency and NC factors in DPSCs. Pharmacological inhibition of the Notch pathway for 48 h, by the γ-secretase inhibitor N-[N-(3,5-Difluorophenacetyl)-L-alanyl]-S-phenylglycine t-butyl ester (DAPT), abolished the expression of NC and core factors. In addition, it induced a silencing of the canonical Wnt signalling and a clear reduction in the stemness potential of DPSCs, as shown by a reduced ability to generate mature, fully differentiated osteoblasts and adipocytes. Conversely, pharmacological activation of the Wnt pathway for 48 h, by either the glycogen synthase kinase 3 beta (GSK3-β) inhibitor 6-bromoindirubin-3´-oxime (BIO) or the human recombinant protein Wnt-3a, not only largely increased the expression of NC and core factors, but also increased the efficiency of DPSCs to differentiate into mature osteoblasts and adipocytes. These results showed that a short preconditioning activation of Wnt/Notch signalling by small molecules and/or recombinant proteins enhanced the stemness and potency of DPSCs in culture, which could be useful for optimising the therapeutic use of these and other tissue-specific stem cells.
Introduction
During embryogenesis, neural crest (NC) cells generate most craniomaxillofacial tissues, including all major tissues of the teeth, except the enamel. The remarkable abilities of the NC prompted its designation as "the fourth embryonic layer" (Shyamala et al., 2015; Thomas et al., 2008) . Importantly, some NC stem cells with a nondifferentiated phenotype remain in the dental pulp of mature teeth and are known as dental pulp stem cells (DPSCs) (Aurrekoetxea et al., 2015; Gronthos et al., 2002; Gronthos et al., 2000; Ibarretxe et al., 2012; Janebodin et al., 2011; Kaukua et al., 2014; Liu et al., 2015) . Other stem cell types with similar properties may be obtained from gingival and periodontal tissues (Abe et al., 2012; Huang et al., 2009; Ibarretxe et al., 2012; Lima et al., 2017; Liu et al., 2015; Petrovic and Stefanovic, 2009 ) and even from periodontal inflammatory lesions, such as human periapical cysts (Marrelli et al., 2013; Marrelli et al., 2015; . Similarly to NC-derived cells, dental stem cells are characterised by the expression of neural crest factors, such as Snail/Snai1, Slug/Snai2, Twist1, Hnk1, Pax3, Neurogenin2 and Sox10 (Kiraly et al., 2009; Schiraldi et al., 2012) , and core factors including Oct4a, Sox2, Klf4, Lin28, stage specific embryonic antigen 3 antibody (Ssea1) and Nanog (Atari et al., 2012; Ferro et al., 2012; Janebodin et al., 2011; Kerkis et al., 2006; Rosa et al., 2016) . Core factors are fundamental in maintaining stem cell pluripotency (Chambers and Tomlinson, 2009; Takahashi et al., 2007; Yu et al., 2007) , thus suggesting that dental stem cells may present some superior features with www.ecmjournal.org V Uribe-Etxebarria et al.
Notch/Wnt crosstalk regulates DPSC stemness respect to other multipotent stem cell populations of the adult human body (Atari et al., 2011; Atari et al., 2012; Rosa et al., 2016) . This could be very relevant for cell therapy because stem cells from dental tissues are known to be easily accessible for extraction and well-tolerated upon grafting, due to their immunesuppressive properties (Pierdomenico et al., 2005) . Furthermore, DPSCs are non-tumourigenic even after their immortalisation by telomerase overexpression (Wilson et al., 2015) . Finally, given that the dental pulp is rather well preserved in mid-to-advanced age patients, DPSCs are also suitable for autologous therapy (Ibarretxe et al., 2012; Kellner et al., 2014; Wu et al., 2015) .
The canonical Notch and Wnt signalling pathways are critical for the maintenance of the stem cell phenotype (Androutsellis-Theotokis et al., 2006; Borghese et al., 2010; Clevers et al., 2014; Perdigoto and Bardin, 2013; Reya and Clevers, 2005) . Both pathways also play an important role in the emergence of the NC (Hari et al., 2012; Leung et al., 2016; Rogers et al., 2012; Stuhlmiller and Garcia-Castro, 2012) . Dental stem cells present higher levels of core factors and Wnt/Notch activity compared to other mesenchymal stem cells in the adult body (Atari et al., 2012; Huang et al., 2009; Janebodin et al., 2011; Vasanthan et al., 2015) . However, the role of these pathways in the maintenance of stemness and self-renewal in DPSCs is still unclear.
Activation of Notch signalling through ligand binding triggers the proteolytic cleavage of Notch receptors, by a disintegrin and metalloproteases (ADAM) followed by γ-secretases, which results in the cleavage and release of the Notch intracellular domain (NICD) from the membrane. NICD translocates to the nucleus where it directly interacts with CSL/RBPj/ CBF-1 transcription factors to turn on the expression of Notch target genes, such as the hairy/enhancer of split (Hes) family (D'Souza et al., 2010) . In the canonical Wnt signalling, the interactions between Wnt protein ligands and Frizzled/LRP receptors lead to the recruitment of axis inhibition protein (AXIN), adenomatous polyposis coli (APC) and glycogen syntase kinase 3 beta (GSK3-β) to the membrane, thus preventing phosphorylation and degradation of β-catenin. As a result, β-catenin accumulates in the cytoplasm and translocates into the nucleus, where it interacts with the T-cell factor/lymphoid enhancer factor (TCF/LEF) family factors and leads to the expression of Wnt signalling target genes (Clevers, 2006) . Both pathways regulate each other at multiple points (Borggrefe et al., 2016; Fukunaga-Kalabis et al., 2015) and promote the maintenance of self-renewal and inhibition of differentiation in many stem cell types, including DPSCs (Mizutani et al., 2007; Scheller et al., 2008; Yiew et al., 2017) .
Pharmacological manipulation of the Notch and Wnt pathways is relatively simple using well-known drugs, such as N-[N-(3,5-Difluorophenacetyl)-L-alanyl]-S-phenylglycine t-butyl ester (DAPT) (γ-secretase inhibitor; Notch signalling blocker) and BIO (GSK3-β inhibitor; Wnt signalling activator), and recombinant activator proteins, such as Wnt-3a. The use of BIO and DAPT has already proven to be a valuable complementary strategy to induce either cellular reprogramming or cellular differentiation (Ichida et al., 2014; Kitajima et al., 2016) . Therefore, a thorough understanding of the stemness and differentiation potential of DPSCs and their modulation by cell signalling pathways would be highly desirable to use these cells more efficiently in areas such as regenerative medicine, tissue engineering and drug screening. In this work, we used DAPT and BIO, as well as human recombinant Wnt-3a, as pharmacological modulators to investigate the role of Notch/Wnt in maintaining the stemness and expression of pluripotency core factors in DPSCs, with the goal of optimising existing protocols for differentiation to somatic cells.
Materials and Methods

DPSC culture
DPSCs were isolated from human third molars obtained from healthy donors between 15 and 30 years of age. The pulp tissue was isolated by fracture and enzymatic digestion for 1 h at 37 °C with 3 mg/mL collagenase (17018-029; Thermo Fisher Scientific, Boston, MA, USA) and 4 mg/mL dispase (17105-041; Thermo Fisher Scientific) followed by mechanical dissociation. DPSCs were cultured in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10 % foetal bovine serum (FBS), 1 mM L-glutamine, 100 U/mL penicillin and 150 µg/ mL streptomycin. DPSCs could be amplified and maintained in these conditions for a very long time (> 6 months). However, to avoid cell aging issues, only DPSCs that had been grown in culture for less than 3 months and had accumulated no more than 6 total passages were used. Comparative experiments between control and treatment conditions were always and without exception performed in parallel using DPSCs from the same donor.
Notch and Wnt pathway pharmacological modulation
To block Notch signalling, 2.5 µM DAPT γ-secretase inhibitor (565784; Calbiochem, San Diego, CA, USA) was added to the culture medium 48 h prior to the assays, where DAPT-treated DPSCs were compared to DPSCs treated only with the control vehicle dimethyl sulfoxide (DMSO). To overactivate Wnt signalling, 2.5 µM 6-bromoindirubin-3´-oxime (BIO), a GSK3-β inhibitor (361550; Calbiochem), was used, which was added to the medium 48 h prior to the assays. BIO-treated cells were compared to DPSCs exposed to 2.5 µM inactive analogue methyl-6-bromoindirubin-3´-oxime (MBIO) (361556; Calbiochem Single-Color Real-Time PCR Detection System (BioRad) using 4.5 µL of Power SYBR ® Green PCR Master Mix 2× (4367659; Applied Biosystems™ Applied Biosystems, Carlsbad, CA, USA), 0.5 µL of primers (0.3125 µM), 0.3 µL of cDNA (1.5 ng/µL) and Nuclease Free water for a total volume reaction of 10 µL. All primers were obtained from public databases and checked for optimal efficiency (> 90 %) under our qPCR experimental conditions. The relative expression of each gene was calculated using the standard 2 -ΔΔCt method (Livak and Schmittgen, 2001 ) and normalised to the average between β-actin and Gapdh, as internal controls. All reactions were performed in triplicate. qPCR was run on an ABI PRISM ® 7000 (Thermo Fisher Scientific). Data were processed by CFX Manager™ software (BioRad). We assessed that all qPCR reactions yielded only one amplification product by the melting curve method. Primer pairs used were obtained through the PrimerBlast method (Primer Bank) and they are listed in Table 1a ,b.
Protein extraction
Cells were washed several times with 0.9 % NaCl and the proteins were extracted with 100 µL of lysis buffer [50 mM Tris-HCl pH 7.5, 1 mM EDTA, 150 mM NaCl, 0.5 % sodium deoxycholate, 0.1 % SDS, 1 % IGEPAL ® CA-630 in dH 2 O and 1 : 100 Proteinase Inhibition Cocktail Set III (539134; Calbiochem)]. Protein quantification was performed before each Western Blot (WB) using the DC TM Protein Assay (5000112; Bio Rad).
Western Blot (WB)
Samples were diluted in NuPAGE sample buffer (NP0007; Novex, Life technologies, Carlsbad, CA, USA) and loaded onto a 4-12 % Invitrogen NuPAGE BisTris Gel (1 mm × 10 wells; NP032180X, Novex, Life Technologies). Subsequently, they were transferred onto 0.45 µm-pore nitrocellulose membranes (Inmmobilon ® Transfer Membranes; Millipore, St. Charles, MO, USA) using a XCell Sure Lock Electrophoresis machine (NP0007; Novex, Life Technologies). For WB analyses, the following antibodies were used: 1 : 1000 rabbit anti β-actin (4967; Cell Signaling Technology (CST), Danvers, MA, USA), 1 : 10000 mouse anti-Gapdh (MAB374; Millipore), 1 : 2000 rabbit anti-PARP (9542S; CST), 1 : 500 rabbit anti-Sox2 (GTX101506; GeneTex, Irvine, CA, USA), 1 : 1000 rabbit anti-Nanog 1,2 (D73G4; CST, 1 : 1000 rabbit anti-Notch 1-receptor intracellular domain (N1ICD) (ab8925; Abcam, Cambridge, UK), 1 : 4000 rabbit anti-total β-catenin (ab6302; Abcam) and 1 : 500 mouse anti-active β-catenin (05-665; Millipore). The secondary antibodies (P0260; DAKO, Hovedstaden, Denmark; NA9340, GE Healthcare, Amersham, UK) were used at a 1 : 2000 dilution. The membranes were stripped using Red Blot reagent (M2504; Inmmobilon ® EMD, Millipore).
Immunofluorescence (IF)
DPSCs cultured on glass coverslips were fixed with 4 % paraformaldehyde for 10 min and washed with PBS. Blocking was performed by 10 min incubation with Normal Goat Serum (501972; Thermo Fisher Scientific). Next, DPSCs were incubated overnight at 4 °C with primary antibodies diluted in PBS + 2 % BSA + 0.1 % Triton X-100. The rabbit anti-N1ICD (ab8925; Abcam), anti-Oct4 (ab19857; Abcam), antic-Myc (ab32[9E10]; Abcam), anti-Ki67 (ab15580; Abcam) and anti-total β-catenin (ab6302; Abcam) antibodies were used at 1 : 200, 1 : 100, 1 : 1000, 1 : 100 and 1 : 3000 dilutions, respectively. Goat anti-rabbit Alexa Fluor (488: A11012; 594: A11012; Invitrogen, Carlsbad, CA, USA) were employed as secondary antibodies at a 1 : 200 dilution, followed by DAPI, used to counterstain cell nuclei. Images were captured with an epifluorescence ZEISS Axioskop (ZEISS, Jena, Germany) operated with Nikon NIS-Elements and an Apotome Confocal Microscope (ZEISS) operated with Nikon DS-Qi1Mc software (Nikon, Tokyo, Japan). Samples fluorescence intensities were quantified by Fiji-ImageJ (Schindelin et al., 2012) after background subtraction.
Cell proliferation and death assays 20 µg/mL propidium iodide (PI; Sigma-Aldrich) was used to detect cell death and 5 µM calcein-AM (Life Technologies) to detect cell viability. Both fluorescent dyes were incubated for 30 min at 37 °C in culture medium and subsequently cells were washed 3 times with PBS. Fluorescence quantification was calculated by microfluorimetry, measuring light emission at 495 nm (calcein-AM: green fluorescence) and 630 nm (PI: red fluorescence) in a Fluoroskan Ascent plate reader (Thermo Fisher Scientific).
Statistical analyses
Statistical analyses were performed with Excel, IBM SPSS Statistics v.9 (SPSS, Chicago, IL, USA) and GrapH Pad v.6 software (Graph Pad Inc., La Jolla, CA, USA). All data sets were subjected to a KolmogorovSmirnov normality test prior to analysis. For small sample sizes, non-parametric tests were chosen by default. Comparisons between only two groups were made using U-Mann Whitney test. Comparisons between multiple groups were made using KruskalWallis followed by Dunn´s post hoc test. p ≤ 0.05 was considered to be statistically significant.
Results
Notch activity was required for the expression of core pluripotency factors and self-renewal of DPSCs
Control DPSCs showed detectable amounts of core pluripotency factors, such as Oct4 (Pou5f1 and Pou5f1p1), Sox2, Nanog, Lin28, Rex1, Stella, Ssea1 and c-Myc, measured by RT-PCR amplicon bands. To assess whether DAPT treatment would affect the expression of core factors in DPSCs, we exposed the DPSC cultures to transient applications of 2.5 µM DAPT for 48 h. Interestingly, for many of these factors, the RT-PCR bands were significantly reduced or lost when the DPSCs were treated with DAPT (Fig.  1a) . As an internal control to assess Notch activity, we examined the expression of the Notch target gene Hes1. A clear decrease in Hes1 expression was consistently observed following DAPT treatment. Next, these changes were validated by qPCR, confirming that all core factors had significantly decreased levels of expression when DPSCs were exposed to DAPT. In some cases, such as that of Rex1 or Ssea1 expression, the decrease in expression was more than 90 % with respect to control (Fig. 1b) . Finally, these changes were also corroborated by IF and WB, where Oct4 (nuclear active form Oct4-a; Atlasi et al., 2008; Ferro et al., 2012; Liedtke et al., 2007) , Sox2, Nanog (canonical isoform 1; Saunders et al., 2013; Wang et al., 2008) , c-Myc and Notch activity marker N1ICD, had also a consistently reduced expression at the protein level (Fig. 1c-l) .
The proliferation rates of DPSCs in the presence or absence of DAPT were compared, to verify if the decreased expression of core factors in DPSCs also reflected a decreased ability for self-renewal and proliferation. DPSCs were incubated with a mixture of calcein-AM/PI, after being cultivated for 48 h in the presence or absence of DAPT. No PI fluorescence was detectable in either condition, indicating that cell viability was not compromised by DAPT treatment. However, calcein fluorescence was reduced by approximately 40 % in the DAPT conditions compared to control (Fig. 2a-c) . To corroborate this result, the number of proliferative cells positive for Ki67, a marker of cell proliferation present during the G1, S, G2 and M phases of the cell cycle, but absent from non-dividing cells (G0), was evaluated. Ki67 labelling was significantly lower in the DAPT-treated DPSCs with respect to controls, thus indicating a reduction in the amount of cycling proliferative cells (Fig. 2e-g ). Finally, it was confirmed that, despite inducing a reduction in DPSC proliferation, DAPT treatment did not cause any genomic damage or apoptotic cell death. The cleaved poly-ADP ribose polymerase (PARP) levels were assessed by WB and resulted negative in all conditions (Fig. 2d) . Taken together, these results suggested that Notch inhibition caused a decrease in the expression of core pluripotency factors in DPSCs, which resulted in decreased self-renewal and proliferation capacities, without affecting cell viability.
Notch and Wnt/β-catenin signalling interacted and positively regulated each other in DPSCs
To assess whether Notch signalling interacted with Wnt/β-catenin signalling in DPSCs, the effect of DAPT treatment on the expression of Wnt signalling targets genes was studied by qPCR. Notch1-4 receptor expression was negatively affected by the treatment, whereas the expression of the Notch ligand Jagged1 was unaffected (Fig. 3a,b) . These results showed an overall downregulation of Notch signalling in DPSCs induced by DAPT treatment. Intriguingly, we also found out that DAPT treatment reduced the expression of the canonical Wnt mediators Wnt-3a and β-catenin and also that of the Wnt target gene
Lef1 by ~50-70 % compared to their respective control values (Fig. 3a,b) . To confirm this result, β-catenin protein levels were assessed both by WB and IF. A significant decrease in the amount of both total and nuclear active β-catenin was found in DPSCs exposed to DAPT for 48 h (Fig. 3c-f) . Therefore, Notch inhibition resulted in a parallel Wnt/β-catenin signalling inhibition in DPSCs. www.ecmjournal.org showing an increase in (k) Sox2, native Nanog1 and Nanog2 isoforms, with slightly different molecular weights, and (l) in both total β-catenin and active β-catenin protein expression. β-actin was used as a protein loading control. * p < 0.05, ** p < 0.01, *** p < 0.001. U-Mann Whitney test.
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BIO-induced Wnt activation enhanced the expression of pluripotency core factors in DPSCs
To investigate whether Wnt/β-catenin activation would enhance the expression of pluripotency core factors in DPSCs, we used BIO treatment for 48 h to hyperactivate Wnt signalling by inhibiting β-catenin degradation. As a control for treatment efficacy, BIO-treated DPSCs showed increased levels of both total and active β-catenin protein, whereas other Wnt targets, such as Lef1, also demonstrated consistently increased expression (Fig. 4a,b ,g,h,k-l). Therefore, BIO induced a strong hyperactivation of Wnt signalling in DPSCs. Then, the expression of pluripotency core factors in BIO-treated DPSCs by RT-PCR and qPCR was assessed. It was determined that BIO also induced overexpression of pluripotency factors at both the transcript (Fig. 4a,b ) and protein levels ( Fig. 4c-k) . In addition to boosting the expression of core pluripotency factors, BIO increased the proliferation ability of DPSCs. As shown by the calcein/PI assay, the number of viable cells in culture significantly increased after BIO treatment (Fig. 5a-c) . Consistently, the Ki67/DAPI fluorescence ratio increased in response to BIO treatment, indicating a greater proportion of active dividing cells (Fig. 5e-g ). Neither PI-positive cells nor an active PARP signal in BIO-treated cells were detected (Fig. 5d) . Together, these experiments demonstrated that Wnt activation by BIO treatment increased the proliferation and selfrenewal capacities of DPSCs without compromising their viability and genomic integrity.
Wnt activation by BIO induced Notch upregulation in DPSCs
Given that DAPT treatment affected Wnt signalling in DPSCs, the question whether Notch activity would also be affected in BIO-treated DPSCs needed addressing. It was found that in BIO-treated DPSCs, most Notch receptors did not undergo any change in expression, except the Notch2 receptor, which was found to be slightly upregulated at the transcript level (Fig. 6a,b) . However, the Notch canonical ligand Jagged1 underwent a much larger 8-fold increase in expression, when the DPSCs were exposed to BIO, followed by Wnt-3a and β-catenin with a ~5-fold increased expression (Fig. 6b) . Moreover, Hes1 was also prominently upregulated, which constituted solid evidence that Notch signalling was being hyperactivated by BIO treatment (Fig. 6b) . Notch signalling upregulation at the protein level was also tested, using an antibody for active cleaved N1ICD. Increased levels of N1ICD were detected for BIOtreated DPSCs by both WB and IF (Fig. 6c-f (Fig. 7a,b) . Other NC gene markers, such as Pax3, Neurogenin2, Twist1 and Hnk1, were also expressed in control DPSCs. However, when DSPCs were cultured with DAPT, the expression of all these markers was downregulated to less than 50 % of the basal levels as assessed by qPCR, with Pax3 being downregulated to more than 90 % of its basal expression (Fig. 7a,b) . Conversely, when cells were cultured with BIO, most markers showed a ~2-fold increased expression compared to control levels, with the notable exception of Pax3, which increased more than 10-fold (Fig. 7c,d ). Some NC gene markers, which presented a very low expression in control DPSCs, such as Sox10, yielded consistent amplicon bands in conventional RT-PCR following BIO treatment. All these changes were corroborated by qPCR (Fig. 7c,d) . Thus, Notch/Wnt activation upregulated the expression of both pluripotency and NC markers in DPSCs.
Wnt/Notch pre-activation enhanced differentiation of DPSCs to osteoblasts and adipocytes Several in vitro protocols can be used to induce terminal differentiation of DPSCs to mature osteoblasts and adipocytes (Gronthos et al., 2002; Langenbach and Handschel, 2013 as controls. Next, control and treated cells were exposed to osteoblastic differentiation medium in the absence of BIO or DAPT. To measure terminal osteoblastic differentiation, ALP and Alizarin Red S assays were used. Interestingly, after 3 weeks of osteogenic treatment, Alizarin Red S staining and calcified matrix deposit formation, as assessed by light absorbance, were between two-and threefold higher in the DPSCs pre-treated with BIO and significantly lower in DPSCs pre-treated with DAPT, when compared to controls (Fig. 8a-d,m) . ALP enzymatic activity was also found to be significantly higher (i.e. osteoblastic differentiation more efficient) when DPSCs were pre-treated with BIO ( Fig. 8e-h,m) . To verify whether Notch/Wnt modulation could also affect DPSC differentiation into adipocytes, DPSCs were exposed to BIO or DAPT for 48 h. Control and treated cells were then exposed to adipogenic differentiation medium for 4 weeks. Oil Red O staining was performed to assess www.ecmjournal.org adipocyte generation. Interestingly, it was found that BIO pre-treatment also enhanced DPSCs conversion to adipocytes as assessed by Oil Red O after the differentiation treatment period. Oil Red O staining was significantly higher in the BIO-pre-treated cells, near twice as much as controls (Fig. 8i-l,n) .
Wnt activation by exposure to human recombinant Wnt-3a protein for 48 h enhanced the expression of NC and pluripotency core factors in DPSCs Since BIO is known to be a general GSK3-β inhibitor (Meijer et al., 2003) , BIO treatment could affect other signalling pathways apart from Wnt. To prove that the observed effects on the expression of core and NC factors and stemness of DPSCs depended specifically on the canonical Wnt signalling pathway, Wnt-3a protein was used, a well-described prototypical canonical Wnt ligand (Famili et al., 2015; Zhang et al., 2009) , to stimulate DPSCs for 48 h in similar conditions to BIO treatment. Two concentrations of human recombinant Wnt-3a were used: 2.5 µM and 5 µM, to verify any possible dose-dependent effects. Interestingly, pluripotency and NC factors showed increased expression when exposed to Wnt-3a, being the effect more pronounced at the concentration of www.ecmjournal.org 5 µM. Among the markers that were most strongly affected Sox2, Oct4 (Pou5f1 and Pou5f1p1), Lin28, Stella, Ssea1, Slug, Hnk1 and Sox10 were detected (all within a ~5-10-fold increase in expression) Pax3 was also present (~30-fold increase with 5 µM Wnt3a). As a control for Wnt activation, Lef1 expression was solidly upregulated after Wnt-3a treatment. All expression changes were verified by RT-PCR and qPCR (Fig. 9a-c) .
Exposure to Wnt-3a upregulated Notch/Wnt crosstalk signalling in DPSCs Verification whether the Notch/Wnt interaction was also required, which was observed after DAPT/BIO treatments, and was also observed after treating cells with Wnt-3a. QPCR experiments had already showed a clear upregulation of Hes1 expression in DPSCs exposed to Wnt-3a (Fig. 9b) . This result was corroborated by IF and a significantly increased N1ICD nuclear fluorescence was found, especially at a concentration of 5 µM Wnt-3a (Fig. 10a-c,k) . Similarly, nuclear β-catenin protein labelling was also found to be increased ( Fig. 10d-f,k) . Finally, similar results were observed for Ki67 labelling levels (Fig.  10g-I,k) . Thus, 5 µM Wnt-3a induced a coordinated upregulation of Notch/Wnt cross-signalling and an increased proliferation capacity in DPSCs.
A preconditioning treatment with human recombinant Wnt-3a enhanced the differentiation capacity of DPSCs to osteoblasts and adipocytes Finally, and in view of the previous results, verification was needed as to whether a preconditioning treatment with Wnt-3a would also render DPSCs V Uribe-Etxebarria et al. Notch/Wnt crosstalk regulates DPSC stemness Fig. 11 . A preconditioning t r e a t m e n t w i t h W n t3a for 48 h enhanced D P S C d i f f e r e n t i a t i o n efficiency into osteoblasts and adipocytes. ( a-c) Alizarin Red S staining t o a s s e s s c a l c i f i e d matrix formation and osteoblast differentiation in control (DMSO) and W n t -3 a ( 2 . 5 µM a n d 5 µM) conditions. (df) ALP staining images at high magnification to detect osteoblastic l i n e a g e c o m m i t m e n t and differentiation in control (DMSO) and Wnt3a (2.5 µM and 5 µM) conditions. (g-i) Oil Red O staining to assess lipid droplet formation and adipocyte differentiation in control (DMSO) and W n t -3 a ( 2 . 5 µ M a n d 5 µM) treatment. more responsive to osteogenic and adipogenic differentiation treatments. DPSCs were exposed to a preconditioning treatment with Wnt-3a for 48 h and subsequently cells were placed in osteogenic and adipogenic culture media, respectively -in similar conditions as shown before with DAPT/BIO. As predicted, pre-treatment with Wnt-3a enhanced the capacity of DPSCs to differentiate to osteoblasts and adipocytes (Fig. 11) . The effect was more pronounced with 5 µM than with 2.5 µM Wnt-3a and was comparable to the one obtained with BIO ( Fig.  8) , with an almost 3-fold increase in Alizarin Red S staining and near to 2-fold increase in Oil Red O staining compared to control, non-pre-treated DPSCs cultures (Fig. 11j) .
Discussion
It was here reported for the first time that both Notch and Wnt signalling were required for the expression of NC and pluripotency core factors in DPSCs. Importantly, both pathways positively regulated each other in maintaining DPSC stemness and specific activation or inhibition of one pathway invariably affected the other in the same way. These findings shed light on the control mechanisms of DPSC self-renewal and maintenance and have important potential implications regarding the use of DPSCs for cell therapy. There are several reasons for the interest in DPSCs and other dental stem cells. These cells are easily www.ecmjournal.org accessible in both young and aged patients, possess a significant capacity for in vitro expansion and have non-tumourigenic phenotypes. Furthermore, evidence shows that DPSCs have a greater multilineage differentiation potential compared to other tissue-specific stem cells (Atari et al., 2012; Kerkis et al., 2006; Rosa et al., 2016) . It is illustrative of the growing acknowledgement of the stemness potential of DPSCs that some authors have referred to some subpopulations of these cells as dental pulp pluripotent stem cells or DPPSCs (Atari et al., 2012) .
Arguably, induced pluripotent stem cells (iPSCs), derived from autologous somatic cells, could be regarded as the ideal source of stem cells for in vivo cell therapy. These cells are truly pluripotent (i.e. have no restriction to differentiate in any type of adult cell), can be extracted from any donor's tissue and have the donor's same genetic background. However, traditional cell reprogramming procedures rely on permanent gene transfection with Yamanaka or related core pluripotency factors (Takahashi et al., 2007) and, for safety reasons, this is not yet acceptable. Hence, while these cell reprogramming technologies are not mature enough for clinical use, the interest in searching for alternative sources of autologous pluripotent-like cells, including DPSCs, is growing very fast. The possibility to boost the natural pluripotency-like features of DPSCs by methods that do not involve permanent chromatin modification or gene transfection is highly desirable for cell therapy.
Canonical Notch and Wnt signalling pathways are described as pivotal regulators of stemness and pluripotency Dravid et al., 2005; Fox et al., 2008; Li and Chen, 2012; Lluis et al., 2008; Lowell et al., 2006; Park et al., 2008; Simandi et al., 2016; Yan et al., 2010) and their pharmacological manipulation has already been tested as a strategy to enhance either cell differentiation (Kitajima et al., 2016) or cell reprogramming (Ichida et al., 2014) . Notch inhibition by γ-secretase blockers is associated with an increased efficiency of keratinocyte reprogramming (Ichida et al., 2014) . However, a very different effect was found in the studied model system with DCPSs: Notch inhibition by DAPT decreased the expression of core factors in DPSCs and diminished their capacity to generate fully differentiated osteoblasts and adipocytes. In this regard, it was worthy to note that Notch effects have long been known to be extremely context-dependent: the same Notch signal can have very different outcomes depending on the cell type, physiological state and extracellular environment. Regarding Wnt signalling, its pharmacological activation by GSK3-β inhibitors in mouse iPSCs is associated with increased cell differentiation (Kitajima et al., 2016) . However, in the DPSC model, BIO application significantly increased the expression of core factors and enhanced DPSC differentiation potential towards adult osteoblasts and adipocytes. Again, these differences were attributed to the different cell culture systems that were tested in this and other studies.
One important difference between the current study and the aforementioned studies was the presence/absence of serum in the culture medium. The use of medium containing FBS is well established as the gold standard for manipulation and in vitro expansion of DPSCs (Gronthos et al., 2002; Gronthos et al., 2000) . In vitro expansion of DPSCs is often inevitable due to the small amounts of tissue material and total cell numbers that can be collected from the human dental pulp, as compared to other stem cell sources. In this regard, despite ongoing progress in culture media formulations that do not contain foetal serum for maintenance of DPSCs (Bonnamain et al., 2013; Eubanks et al., 2014; Jung et al., 2016; Xiao and Tsutsui, 2013) , currently the addition of FBS or related agents to the culture media permits easily overcoming the issue of initial cell expansion. However, it is becoming increasingly apparent that FBS-containing media also induce differentiation of DPSCs into a default osteo/odontogenic pathway (Pisciotta et al., 2012; Yu et al., 2010) and this may not be the best choice to generate certain cell lineages, particularly neural cells, from DPSCs (Jung et al., 2016) . Moreover, upon continual expansion induced by the presence of 10 % FBS, DPSC cultures also tend to generate populations of committed/differentiated cells (Mokry et al., 2010) . Therefore, progressive stem cell exhaustion was also a concern in this study. We confirmed that the proliferation rates and core factor expression decreased steadily in DPSCs upon serial passaging (data not shown). This correlation between sustained stem cell aging and loss of multipotency is also reported elsewhere (Bose and Shenoy, 2016) .
One important finding of this study was that Notch and Wnt pathways operated coordinately as part of a common network to maintain DPSC stemness. We found that the expression of core factors in DPSCs was completely dependent upon Notch/Wnt signalling. Notch inhibition by DAPT applications abolished the expression of core factors and decreased DPSC stemness. These results were accompanied by parallel Wnt inhibition. Conversely, Wnt activation by BIO or Wnt-3a significantly increased the expression of core factors and DPSC stemness. In view of this evidence, the question became what connection do these pathways have at the molecular level? Many positive and negative interactions are reported between both pathways in a myriad of model systems (Borggrefe et al., 2016; Fukunaga-Kalabis et al., 2015; Kwon et al., 2011; Nicolas et al., 2003; Shi et al., 2015) . In colorectal cancer cells, Wnt signalling affects Notch through β-catenin-mediated transcriptional activation of the gene Jagged1 (Rodilla et al., 2009) . Jagged1 is a Notch ligand, which can activate Notch receptors and, consequently, Notch signalling. Consistently, BIOinduced Wnt activation in DPSCs elicited a sharp increase in the transcriptional levels of Jagged1. It is likely that such an increased Jagged1 transcription would eventually activate Notch receptors in DPSCs cultures. In addition, β-catenin physically binds to and interacts with reprogramming factors, in www.ecmjournal.org V Uribe-Etxebarria et al.
Notch/Wnt crosstalk regulates DPSC stemness particular Oct4a (Simandi et al., 2016) , whereas Oct4a transcription levels are also positively regulated by Wnt signalling in pluripotent stem cells (Li and Chen, 2012; Simandi et al., 2016) . Finally, Wnt/β-catenin also increases c-Myc transcription, which promotes cell proliferation (Barker et al., 2000) . Consistently, DPSCs treated with BIO or Wnt-3a showed an increased transcription of c-Myc, which was related to an increased cell proliferation. Together with enhanced core factor expression, activation of the Notch/Wnt signalling pathways also increased the expression of NC markers in DPSCs. Both Notch and Wnt signals are associated with NC induction (Gazarian and Ramirez-Garcia, 2017; Hari et al., 2012; Leung et al., 2016; Rogers et al., 2012; Stuhlmiller and Garcia-Castro, 2012) . Indeed, NC cells also express relatively high levels of core factors, which possibly relates to their ample capacity to generate very diverse cell lineages (Thomas et al., 2008) . It was found that the NC markers Pax3, Hnk1, Twist, Neurogenin2, Snail/Snai1, Slug/Snai2 and Sox10 had increased expression levels when the DPSCs were exposed to Wnt-3a or BIO and that their expression decreased in the presence of DAPT, thus showing a similar relationship to the one found with pluripotency core factors.
The results demonstrated that Wnt/Notch activation increased DPSC stemness. This could have important implications for optimising the clinical use of these cells. A short preconditioning treatment with Wnt-3a or BIO for 48 h was enough to improve the potential of DPSC to differentiate into at least two different adult cell lineages, osteoblasts and adipocytes, which are both of mesenchymal origin. This very important finding proved that DPSC exhaustion by continuous exposure to FBS could be at least partially prevented by transiently boosting the activity of Notch/Wnt pathways, by means of small molecules and/or recombinant proteins, which would enhance stemness traits of DPSC cultures just 48 h before use for differentiation or cell transplant. It would also be very interesting to verify whether such preconditioning would also be effective for other non-mesenchymal cell lineages of interest, such as Schwann cells (Martens et al., 2014) , neuron-like cells (Gervois et al., 2015) and hepatocyte-like cells (Atari et al., 2012) . Finally, the adoption of this preconditioning strategy could also be applicable to differentiation protocols that do not rely on FBS (Eubanks et al., 2014; Xiao and Tsutsui, 2013) , allowing for a faster translation to clinical therapy.
Conclusions
Our data showed that Notch and Wnt signalling were required for the maintenance of NC and core pluripotency factor expression in DPSCs. Furthermore, both pathways operated coordinately as part of the same signalling network to maintain DPSC stemness. Thus, a 48 h Notch/Wnt signalling activation preconditioning step by BIO or Wnt-3a significantly enhanced the capacity of DPSCs to respond to standard in vitro protocols for osteoblastic and adipogenic differentiation. Conversely, Notch/ Wnt inhibition decreased DPSC stemness. These preconditioning changes involved levels of expression of core pluripotency and NC factors, which correlated with an enhanced differentiation potential of DPSCs. This strategy could be used alone or in conjunction with other cell reprogramming methods that do not involve permanent gene transduction or modifications at genome level to generate DPSCs and other tissue-specific adult stem cells with increased self-renewal and cell differentiation potential for cell therapy.
